Pfizer locks out workers at Indian manufacturing plant
- According to Pfizer, there have been numerous disciplinary incidents, threats to management and production disruptions at its plant in Thane, India.
- There are 212 workers at the Thane manufacturing plant.
- Although the plant has ceased operations temporarily while the dispute is resolved, there is a back-up plan to continue manufacturing Pfizer medications in India.
Pfizer India, headquartered in Mumbai, has 4,000 employees nationwide. The incident involving 212 workers would appear to be minor given the size of the overall workforce.
Nonetheless, this event has been widely reported and there is a frustrating lack of available details that might help elucidate the dispute's origins. While there is certainly enough manufacturing capacity to continue production in the short-term, Pfizer and its investors would be best-served by a speedy resolution of this conflict.